Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

ZX-101A inhibits tumor growth by enhancing antitumor immunity

April 20, 2021

TP-5809 shows potent inhibition of tumor growth in a model of Hodgkin's lymphoma

April 20, 2021

BO-2762: a potential candidate for colorectal cancer

April 20, 2021

Betta Pharmaceuticals identifies IDH2 mutant inhibitors

April 20, 2021

Roche discloses MGL inhibitors

April 20, 2021

BeiGene patents new PROTACs for cancer

April 20, 2021

Genentech's GNE-7883 inhibits YAP/TAZ-TEAD interaction

April 20, 2021

Zenshine PI3Kgamma inhibitor ZX-4081 functions by reprogramming the tumor microenvironment

April 20, 2021

Loxo Oncology presents next-generation RET inhibitor candidates

April 19, 2021

Shenzhen Targetrx Biotechnology synthesizes Ret inhibitors

April 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...